You are here

Antihypertensive medication use and change in kidney function in elderly adults: a marginal structural model analysis.

TitleAntihypertensive medication use and change in kidney function in elderly adults: a marginal structural model analysis.
Publication TypeJournal Article
Year of Publication2011
AuthorsOdden, MC, Tager, IB, van der Laan, MJ, Delaney, JAC, Peralta, CA, Katz, R, Sarnak, MJ, Psaty, BM, Shlipak, MG
JournalInt J Biostat
Volume7
Issue1
PaginationArticle 34
Date Published2011
ISSN1557-4679
KeywordsAged, Antihypertensive Agents, Cystatin C, Data Interpretation, Statistical, Female, Glomerular Filtration Rate, Humans, Hypertension, Kidney, Longitudinal Studies, Male, Models, Statistical
Abstract<p><b>BACKGROUND: </b>The evidence for the effectiveness of antihypertensive medication use for slowing decline in kidney function in older persons is sparse. We addressed this research question by the application of novel methods in a marginal structural model.</p><p><b>METHODS: </b>Change in kidney function was measured by two or more measures of cystatin C in 1,576 hypertensive participants in the Cardiovascular Health Study over 7 years of follow-up (1989-1997 in four U.S. communities). The exposure of interest was antihypertensive medication use. We used a novel estimator in a marginal structural model to account for bias due to confounding and informative censoring.</p><p><b>RESULTS: </b>The mean annual decline in eGFR was 2.41 ± 4.91 mL/min/1.73 m(2). In unadjusted analysis, antihypertensive medication use was not associated with annual change in kidney function. Traditional multivariable regression did not substantially change these estimates. Based on a marginal structural analysis, persons on antihypertensives had slower declines in kidney function; participants had an estimated 0.88 (0.13, 1.63) ml/min/1.73 m(2) per year slower decline in eGFR compared with persons on no treatment. In a model that also accounted for bias due to informative censoring, the estimate for the treatment effect was 2.23 (-0.13, 4.59) ml/min/1.73 m(2) per year slower decline in eGFR.</p><p><b>CONCLUSION: </b>In summary, estimates from a marginal structural model suggested that antihypertensive therapy was associated with preserved kidney function in hypertensive elderly adults. Confirmatory studies may provide power to determine the strength and validity of the findings.</p>
DOI10.2202/1557-4679.1320
Alternate JournalInt J Biostat
PubMed ID22049266
PubMed Central IDPMC3204667
Grant ListN01-HC-451 / HC / NHLBI NIH HHS / United States
L30 AG038029 / AG / NIA NIH HHS / United States
AG-20098 / AG / NIA NIH HHS / United States
N01-HC-85086 / HC / NHLBI NIH HHS / United States
AG-027058 / AG / NIA NIH HHS / United States
N01-HC-35129 / HC / NHLBI NIH HHS / United States
N01 HC-55222 / HC / NHLBI NIH HHS / United States
T32 HP-19025 / / PHS HHS / United States
N01-HC-75150 / HC / NHLBI NIH HHS / United States
N01 HC-15103 / HC / NHLBI NIH HHS / United States
R01 AG-027002 / AG / NIA NIH HHS / United States
AG-15928, / AG / NIA NIH HHS / United States
N01-HC-85079 / HC / NHLBI NIH HHS / United States
HL080295 / HL / NHLBI NIH HHS / United States
N01-HC-85239 / HC / NHLBI NIH HHS / United States
AG-023629 / AG / NIA NIH HHS / United States